Mahana Therapeutics
ClosedUnited States · $61.0M raised
- Business Model
- B2B2C
- Website
- mahana.com
- Total Funding
- $61.0M
- Last Round
- $61.0M Series BAug 2021
- Rounds
- 1
About
Developer of FDA-cleared digital therapeutics for chronic health conditions, with a focus on gastrointestinal disorders like IBS.
Summary
Mahana Therapeutics is a Biotech company based in United States. It has raised $61.0M in total across 1 round, most recently a $61.0M Series B round in Aug 2021. Investors include Jazz Venture Partners, Gurnet Point Capital and Main Street Advisors.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Aug 2021
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...